Norway: King Harald's Health Has 'Deteriorated,' Palace Says
Summarized and contextualized by DistantNews.
At a glance
- Norway's King Harald V's health has deteriorated while hospitalized, according to the royal household.
- The 89-year-old monarch is being treated for a bacterial infection in his blood and hemolytic anemia.
- The King has been on sick leave for two weeks and has canceled upcoming engagements, with Crown Prince Haakon acting as regent.
The health of Norway's King Harald V has taken a turn for the worse during his hospital stay, the royal household announced Sunday. The 89-year-old monarch is currently receiving treatment for a bacterial infection in his blood, a condition that has caused his health to deteriorate over the weekend.
King Harald is also being treated for hemolytic anemia, a disorder characterized by the rapid destruction of red blood cells, leading to fatigue, weakness, and paleness. The palace stated that while his health has worsened, he has responded to antibiotic treatment for the infection and his condition remains stable.
His Majesty the King's health deteriorated over the weekend. The King is receiving antibiotics for a bacterial infection in his blood, and โhas responded to this treatment.
Previously admitted to Oslo University Hospital on Monday due to fluid retention related to cortisone treatment, the King was placed on a two-week sick leave. This leave has led to the cancellation of his planned visit to the Trondelag region in early September. During his absence, Crown Prince Haakon is serving as regent.
This health setback adds to a challenging year for the Norwegian royals. King Harald, Europe's oldest reigning monarch, has a history of health issues, including a pacemaker and previous hospitalizations for infections. The family has also faced public scrutiny due to scandals involving other members.
The disorder causes fatigue, weakness, shortness of breath and paleness.
Originally published by Tempo. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.